Recombinant Rat TFF2 Protein Pre-coupled Magnetic Beads

• Cat.No.: TFF2-5688R-B
• Product Overview: The Recombnant protein was conjugated to magnetic beads. This ready-to-use, pre-coupled magnetic beads are in uniform particle size and narrow size distribution with large surface area, which is conducive to convenient and fast capture target molecules with high specificity and achieve magnetic separation. This product can be equipped with automation equipment for high-throughput operations.

Specification

• Source: HEK293
• Species: Rat
• Form: Solution
• Particle size: ~2 μm
• Beads Surface: Hydrophilic
• Capacity: > 200 pmol rabbit IgG/ mg beads
• Applications: Immunoassay, In vitro diagnostics, cell sorting, Immunoprecipitation/Co-precipitation, Protein/antibody separation and purification.
• Stability: Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions.
• Storage: 2-8℃. Do not to freeze thaw the Beads
• Concentration: 10mg beads/mL
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Tff2 trefoil factor 2 [ Rattus norvegicus ]
• Official Symbol: TFF2
• Gene ID: 116592
• mRNA Refseq: NM_053844.1
• Protein Refseq: NP_446296.1
• UniProt ID: Q09030

Reviews

03/14/2020

The manufacturer's technical support can also aid researchers in the data analysis phase.

12/17/2018

the manufacturer's technical support is instrumental in assisting researchers throughout their trials.

04/15/2016

They can provide valuable guidance in experimental design, optimization, and troubleshooting, helping researchers overcome challenges and maximize the efficiency of their trials.

Q&As

How does TFF2 protein contribute to the protection of the gastric mucosa?

TFF2 promotes the formation of a protective mucous layer on the stomach lining, preventing damage from stomach acid and other harmful factors.

Can TFF2 protein be administered orally for clinical applications?

Researchers are exploring various methods of delivering TFF2 protein, including oral administration, to treat gastrointestinal conditions.

In what ways is TFF2 protein being studied for potential therapeutic applications in IBD?

TFF2 is being investigated for its potential to reduce inflammation and promote mucosal healing in IBD patients.

Are there ongoing clinical trials or research investigating the therapeutic potential of TFF2 protein?

Yes, there are ongoing studies exploring the use of TFF2 protein in the treatment of various gastrointestinal disorders.

How does TFF2 protein compare to other treatments for gastric ulcers or IBD?

TFF2 protein-based therapies may offer an alternative or complementary approach to traditional treatments for these conditions.